LRATD2 and neoplasm: Subcutaneous injection of PC-3 cells was used to induce tumor growth, and knockdown of Lig3 inhibited the growth of xenograft tumors and reduced tumor weight, which was reversed by overexpression of FAM84B (Fig. 2F).